COVID-19: Test Developers Focus On New Variants
Researchers discussed ways to ensure COVID-19 diagnostics work for all variants during a recent webinar.
You may also be interested in...
The US agency’s immediately-in-effect guidance document – released on 22 February – explains how makers of COVID-19 diagnostics can assess whether their tests are impacted by mutations of the virus.
Sponsors participating in the US FDA’s Accreditation Scheme for Conformity Assessment pilot program should work closely with the lab and be prepared for a few extra steps in putting a submission together, agency staff say.
The $1.5tn proposal includes limited information about the US FDA, but makes pandemic recovery a clear priority.